Merck’s Covid-19 Pill Receives Approval from UK Regulators
Merck’s (NYSE: MRK) covid-19 pill, molnupiravir, was approved by the UK Medicines and Healthcare Products Regulatory Agency on Thursday. The treatment is the first oral antiviral used to treat mild-to-moderate Covid-19 within adults that are at risk for severe illnesses. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” assets=”MRK” api=”yf”] [stock_market_widget type=”chart” template=”basic” color=”orange” assets=”MRK” range=”1mo” interval=”1d” axes=”true” cursor=”true” …
Merck’s Covid-19 Pill Receives Approval from UK Regulators Read More »